Page 17 - Erişkinlerde Hastanede Gelişen Pnömoni Tanı ve Tedavi Uzlaşı Raporu

Türk Toraks Derneği Erişkinlerde Hastanede Gelişen Pnömoni Tanı ve Tedavisi Uzlaşı Raporu

50. Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator- patients who developed ventilator associated pneumonia. Ann
associated pneumonia: its relevance to developing effective Thorac Med 2015;10:137-42.
strategies for prevention. Respir Care 2005;50:739-41. 69. Bloos F, Marshall JC, Dellinger RP, et al. Multinational observa-
51. Garrouste-Orgeas M, Chevret S, Arlet G, et al. Oropharyngeal tional study of procalcitonin in ICU patients with pneumonia
or gastric colonization and nosocomial pneumonia in adult in- requiring mechanical ventilation: a multicenter observational
tensive care unit patients. A prospective study based on geno- study. Crit Care 2011;15:R88.
mic DNA analysis. Am J Respir Crit Care Med 1997;156:1647- 70. Hellyer TP, Morris AC, McAuley DF, et al. Diagnostic accu-
55. racy of pulmonary host inflammatory mediators in the exclu-
52. Nseir S, Di Pompeo C, Pronnier P, et al. Nosocomial tracheob- sion of ventilator associated pneumonia. Thorax 2015;70:41-
ronchitis in mechanically ventilated patients: incidence, aetio- 7.
logy and outcome. Eur Respir J 2002;20:1483-9. 71. Zilberberg MD, Shorr AF. Ventilator associated pneumonia: The
53. Rello J, Quintana E, Ausina V, et al. Incidence, etiology, and clinical pulmonary infection score as a surrogate for diagnostics
outcome of nosocomial pneumonia in mechanically ventilated and outcome. Clin Infect Dis 2010;51:S131-S5.
patients. Chest 1991;100:439-44. 72. Shan J, Chen HL, Zhu JH. Diagnostic accuracy of clinical pul-
54. Dodek P, Keenan S, Cook D, et al. Evidence-based clinical prac- monary infection score for ventilator-associated pneumonia: a
tice guidelines for the prevention of ventilator-associated pneu- meta-analysis. Respir Care 2011;56:1087-94.
monia. Ann Intern Med 2004;141:305-13. 73. Karacan Ö, Altaş O, Savaş Ş, et al. Yoğun Bakım Ünitelerimizde-
55. Wunderink RG, Woldenberg LS, Zeiss J, et al. The radiologic ki Alt Solunum Yolu İnfeksiyonları: 3 Yıllık Analiz. Yoğun Bakım
diagnosis of autopsy-proven ventilator associated pneumonia. Dergisi 2004;4:61-8.
Chest 1992;101:458-63. 74. Öncül A, Koçulu S, Elevli K. Bir Devlet Hastanesi’nin yoğun
56. Carraro E, Cook C, Evans D, et al. Lack of added predictive value bakım ünitelerinde kazanılan hastane enfeksiyonlarının epide-
of portablo chest radiography in diagnosing ventilator associa- miyolojisi: Şişli Etfal Hastanesi Tıp Bülteni 2012;46:60-5.
ted pulmonary infection. Surg Infect (Larchmt) 2014;15:739-44. 75. Nseir S, Favory R, Jozefowicz E, et al. Antimicrobial treatment
57. Craven DE, Hjalmarson KI. Ventilator associated tracheobronc- for ventilator-associated tracheobronchitis: a randomized, cont-
hitis and pneumonia: thinking outside of the box. Clin Infect Dis rolled, multicenter study. Crit Care 2008;12:R62.
2010;51:S59-66. 76. Nseir S, Di Pompeo C, Soubrier S, et al. Outcomes of ventilated
58. Zagli G, Cozzolino M, Terreni A, et al. Diagnosis of ventila- COPD patients with nosocomial tracheobronchitis: a case-cont-
tor-associated pneumonia: a pilot, exploratory analysis of a rol study. Infection 2004;32:210-6.
new score based on procalcitonin and chest echography. Chest 77. Dallas J, Skrupky L, Abebe N, et al. Ventilator-associated trac-
2014;146:1578-85. heobronchitis in a mixed surgical and medical ICU population.
59. Mongodi S, Via G, Girard M, et al. Lung ultrasound for early diag- Chest 2011;139:513-8.
nosis of ventilator associated pneumonia. Chest 2016;149:969- 78. Martin-Loeches I, Povoa P, Rodriguez A, et al. Incidence and
80. prognosis of ventilator-associated tracheobronchitis (TAVeM):
60. Wang G, Ji X, Xu Y, et al. Lung ultrasound: a promising tool to a multicentre, prospective, observational study. Lancet Respir
monitor ventilator associated pneumonia in critically ill pati- Med 2015;3:859-68.
ents. Crit Care 2016;20:320. 79. Nseir S, Martin-Loeches I, Makris D, et al. Impact of appropriate
61. Tıbbi Mikrobiyoloji Uzmanları için Klinik Örnekten Sonuç Ra- antimicrobial treatment on transition from ventilator-associated
poruna Uygulama Rehberi, Solunum Sistemi Örnekleri, Klinik tracheobronchitis to ventilator-associated pneumonia. Crit Care
Mikrobiyoloji Uzmanlık Derneği Yayınları No: 10, Aralık 2015, 2014;18:R129.
Ankara ISBN: 978-605-84108-5-5, Çağhan Ofset Matbaacılık 80. Kollef MH. How I diagnose and manage ventilator associated
Ltd Şti. tracheobronchitis. Med Intensiva 2016;40:176-8.
62. Berton DC, Kalil AC, Teixeira PJ. Quantitative versus qualitative 81. Guillamet CV, Vazquez R, Noe J, et al. A cohort study of
cultures of respiratory secretions for clinical outcomes in pati- bacteremic pneumonia: The importance of antibiotic resis-
ents with ventilator-associated pneumonia. Cochrane Database tance and appropriate initial therapy? Medicine (Baltimore).
Syst Rev 2014;30:CD006482. 2016;95(35):e4708.
63. Waters B, Muscedere J. A 2015 update on ventilator-associated 82. Enne VI, Personne Y, Grgic L, et al. Aetiology of hospital-ac-
pneumonia: new insights on its prevention, diagnosis, and treat- quired pneumonia and trends in antimicrobial resistance. Curr
ment. Curr Infect Dis Rep 2015;17:496. Opin Pulm Med 2014;20:252-8.
64. Tasbakan MS, Gurgun A, Basoglu OK, et al. Comparison of 83. Boyce JM, Pop OF, Abreu-Lanfranco O, et al. A trial of dis-
bronchoalveolar lavage and mini-bronchoalveolar lavage in the continuation of empiric vancomycin therapy in patients with
diagnosis of pneumonia in immunocompromised patients. Res- suspected methicillin-resistant Staphylococcus aureus health
piration 2011;81:229-35. care-associated pneumonia. Antimicrob Agents Chemother
65. Agbaht K, Diaz E, Munoz E, et al. Bacteremia in patients with 2013;57:1163-8.
ventilator-associated pneumonia is associated with increased 84. Arthur LE, Kizor RS, Selim AG, et al. Antibiotics for venti-
mortality: a study comparing bacteremic vs. nonbacteremic lator-associated pneumonia. Cochrane Database Syst Rev
ventilator-associated pneumonia. Crit Care Med 2007;35:2064- 2016;10:CD004267.
70. 85. Ewan V, Hellyer T, Newton J, et al. New horizons in hospital
66. Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided inter- acquired pneumonia in older people. Age Ageing 2017;46:352-
ventions against infections to increase early appropriate antibi- 58.
otics and improve survival in the intensive care unit: a randomi- 86. Uni M, Nishimura N, Yamano Y, et al. Efficacy of early switch
zed trial. Crit Care Med 2011;39:2048-58. from intravenous to oral antimicrobials in patients with aspirati-
67. Liu D, Su LX, Guan W, et al. Prognostic value of procalcitonin on pneumonia: A prospective observational study. Respir Inves-
in pneumonia: A systematic review and meta-analysis. Respiro- tig 2015;53: 225-31.
logy 2016;21:280-8. 87. Lee RW, Lindstrom ST. Early switch to oral antibiotics and early
68. Tanriverdi H, Tor MM, Kart L, et al. Prognostic values of se- discharge guidelines in the management of community-acqui-
rum procalcitonin and C reactive protein levels in critically ill red pneumonia. Respirology 2007;12:111-6.